(0.34%) 5 117.28 points
(0.29%) 38 350 points
(0.31%) 15 978 points
(-0.66%) $83.30
(2.55%) $1.972
(0.01%) $2 347.40
(-0.01%) $27.53
(3.03%) $950.05
(-0.11%) $0.934
(-0.13%) $11.01
(-0.33%) $0.798
(1.77%) $93.50
0.81% KRW 6 200.00
Live Chart Being Loaded With Signals
Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments...
Stats | |
---|---|
Dzisiejszy wolumen | 97 884.00 |
Średni wolumen | 689 294 |
Kapitalizacja rynkowa | 408.25B |
EPS | KRW0 ( 2024-04-22 ) |
Następna data zysków | ( KRW0 ) 2024-05-13 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW7.25 (0.12%) |
Wolumen Korelacja
Bukwang Pharmaceutical Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bukwang Pharmaceutical Korelacja - Waluta/Towar
Bukwang Pharmaceutical Finanse
Annual | 2023 |
Przychody: | KRW125.93B |
Zysk brutto: | KRW50.05B (39.74 %) |
EPS: | KRW-457.67 |
FY | 2023 |
Przychody: | KRW125.93B |
Zysk brutto: | KRW50.05B (39.74 %) |
EPS: | KRW-457.67 |
FY | 2022 |
Przychody: | KRW190.91B |
Zysk brutto: | KRW79.43B (41.61 %) |
EPS: | KRW-62.07 |
FY | 2021 |
Przychody: | KRW182.49B |
Zysk brutto: | KRW75.76B (41.51 %) |
EPS: | KRW-8.74 |
Financial Reports:
No articles found.
Bukwang Pharmaceutical
Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various therapeutic areas, including liver disease treatments, such as Levovir and Legalon; diabetic complication products comprising Dexid and Thioctacid; CNS disorder drugs consisting of Lonasen, Ixel, and Orfil; and respiratory disease treatments, which comprise Azeptin and Asima. It also provides OTC products; toothpastes, and hair and skin care goods; and nutritional supplements. In addition, the company offers products for antihistamines, hepatitis and gastrointestinal, sedative and antidote, anti-cancer, thyroid and osteoporosis, diabetes, obstetrics, urinogenital, cardiovascular, dermatology, obesity, pain relief, and muscle relaxant. Further, it provides products for bruises, skin and mucous membrane, rhinitis, cold symptoms, cough, phlegm and asthma, rheumatoid arthritis, osteoarthritis, pain caused by cold and fever, dysmenorrhea, NSAIDs, inflammation, joint inflammation, tinea pedis, infected wounds, dermatitis, antivirals-herpes, eczema, diarrhea, dyspepsia, sense of distension, anti-histamine, anti-ulcer, constipation, anemia, pregnant multivitamins, candidiasis, athlete's foot, onychomycosis, stomatitis, pimple, acne, physical fatigue, neuralgia, myalgia, and arthralgia. Additionally, the company offers medicines for period of lactation, rickets, night blindness, varicose vein, and sputum; and quasi drugs and medical devices, as well as health functional food. It also develops anti-diabetes compound with Melior Pharmaceuticals; and anti-cancer drugs with LSK BioPartners, as well as cell therapies using adult stem cells, as well as holds a license for a novel candidate to treat movement disorder in Parkinson's disease patients. The company was founded in 1960 and is based in Seoul, South Korea.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej